LEADS BIOLABS-B Shares Surge 6% in Afternoon Session on Potential Inclusion in Southbound Trading Scheme

Deep News

02/23

LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million.

Following the recent quarterly review results announced by Hang Seng Indexes Company, LEADS BIOLABS has been included in the Hang Seng Composite Index. All changes will take effect after the market close on March 6 and will be implemented starting March 9. A research report from CICC indicated that LEADS BIOLABS could potentially be added to the Southbound Stock Connect scheme in March. Meanwhile, Western Securities noted that, considering the company's multiple clinical data catalysts expected in 2026, a commercial inflection point is anticipated by 2027.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1199865714"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1199865714\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1199865714?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-23 15:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199865714","market":"sh","top_or_hot":-1,"title":"LEADS BIOLABS-B Shares Surge 6% in Afternoon Session on Potential Inclusion in Southbound Trading Scheme","media":"Deep News","content":"<p>LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million.</p>\n<p>Following the recent quarterly review results announced by Hang Seng Indexes Company, LEADS BIOLABS has been included in the Hang Seng Composite Index. All changes will take effect after the market close on March 6 and will be implemented starting March 9. A research report from CICC indicated that LEADS BIOLABS could potentially be added to the Southbound Stock Connect scheme in March. Meanwhile, Western Securities noted that, considering the company's multiple clinical data catalysts expected in 2026, a commercial inflection point is anticipated by 2027.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LEADS BIOLABS-B Shares Surge 6% in Afternoon Session on Potential Inclusion in Southbound Trading Scheme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLEADS BIOLABS-B Shares Surge 6% in Afternoon Session on Potential Inclusion in Southbound Trading Scheme\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time smaller\">2026-02-23 15:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million.</p>\n<p>Following the recent quarterly review results announced by Hang Seng Indexes Company, LEADS BIOLABS has been included in the Hang Seng Composite Index. All changes will take effect after the market close on March 6 and will be implemented starting March 9. A research report from CICC indicated that LEADS BIOLABS could potentially be added to the Southbound Stock Connect scheme in March. Meanwhile, Western Securities noted that, considering the company's multiple clinical data catalysts expected in 2026, a commercial inflection point is anticipated by 2027.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HK0000252160.HKD","symbol_name":"易方達 (香港) 中國股票股息基金A 類 (分派) 港元","start_time":0,"source_url":"","article_id":"1199865714","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199865714","pubTimestamp":1771830019,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million. Following the recent quarterly review...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HK0000252160.HKD":"易方达 (香港) 中国股票股息基金A 类 (分派) 港元","VT":"世界全股市ETF-Vanguard","BK4585":"ETF&股票定投概念","HK0000500386.USD":"易方达 (香港) 中国股票股息基金A 类 (累积) 美元","BK4588":"碎股","HK0000252152.HKD":"易方达 (香港) 中国股票股息基金A 类 (累积) 港元","BK1161":"生物科技","09887":"维立志博-B","VXUS":"国际股票ETF-Vanguard"},"translate_title":"领先BIOLABS-B股价午后飙升6%，因可能纳入港股通交易计划","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VT":1,"09887":1,"VXUS":1},"content_text":"LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million.\nFollowing the recent quarterly review results announced by Hang Seng Indexes Company, LEADS BIOLABS has been included in the Hang Seng Composite Index. All changes will take effect after the market close on March 6 and will be implemented starting March 9. A research report from CICC indicated that LEADS BIOLABS could potentially be added to the Southbound Stock Connect scheme in March. Meanwhile, Western Securities noted that, considering the company's multiple clinical data catalysts expected in 2026, a commercial inflection point is anticipated by 2027.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}